Close
  • Home

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

Funding

Clinical  ·  Weekly Digest 11 Jan to 17 Jan 2025
Celltrion unveils strategic vision for advancing its innovative drug pipeline at the 43rd Annual J.P. Morgan Healthcare Conference

Weekly Digest – January 2025 Weekly Digest – January 2025 15 Jan 2025: Celltrion unveils strategic vision for advancing its innovative drug pipeline at the 43rd Annual J.P. Morgan Healthcare Conference Celltrion unveiled its strategic roadmap for innovative drug development, […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest 11 Jan to 17 Jan 2025
Zai Lab announces positive topline results for TIVDAK in the China subpopulation of the global phase 3 innovaTV 301 trial in patients with recurrent or metastatic Cervical Cancer

Weekly Digest – January 2025 Weekly Digest – January 2025 15 Jan 2025: Zai Lab announces positive topline results for TIVDAK in the China subpopulation of the global phase 3 innovaTV 301 trial in patients with recurrent or metastatic Cervical […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest 11 Jan to 17 Jan 2025
Elevation Oncology provides updates on differentiated ADC programs and upcoming milestones

Weekly Digest – January 2025 Weekly Digest – January 2025 13 Jan 2025: Elevation Oncology provides updates on differentiated ADC programs and upcoming milestones Elevation Oncology initiated dosing in a Phase 1 clinical trial evaluating EO-3021, a Claudin 18.2 ADC, […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest 11 Jan to 17 Jan 2025
Daiichi Sankyo acquires Intellectual Property Rights for anti-TAMUC1 antibody in DS-3939 from Glycotope GmbH

Weekly Digest – January 2025 Weekly Digest – January 2025 13 Jan 2025: Daiichi Sankyo acquires Intellectual Property Rights for anti-TAMUC1 antibody in DS-3939 from Glycotope Daiichi Sankyo has agreed to pay $132.5 million to Glycotope to acquire the intellectual […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 04 Jan to 10 Jan 2025
Mabwell’s Nectin-4 targeted ADC 9MW2821 combination therapy demonstrates 87.5% ORR and granted CDE Breakthrough Therapy Designation

Weekly Digest – January 2025 Weekly Digest – January 2025 09 Jan 2025: Mabwell’s Nectin-4 targeted ADC 9MW2821 combination therapy demonstrates 87.5% ORR and Granted CDE Breakthrough Therapy Designation Mabwell  announced that its Nectin-4 targeted ADC (9MW2821) received Breakthrough Therapy […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 04 Jan to 10 Jan 2025
China’s National Medical Products Administration (NMPA) approves Padcev in combination with Keytruda (Pembrolizumab) for the treatment of advanced bladder cancer

Weekly Digest – January 2025 Weekly Digest – January 2025 08 Jan 2025: China’s National Medical Products Administration (NMPA) approves Padcev in combination with Keytruda (Pembrolizumab) for the treatment of advanced bladder cancer China’s NMPA has approved enfortumab vedotin in […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 04 Jan to 10 Jan 2025
GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives US FDA Breakthrough Therapy Designation in late-line relapsed or refractory osteosarcoma

Weekly Digest – January 2025 Weekly Digest – January 2025 07 Jan 2025: GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives US FDA Breakthrough Therapy Designation in late-line relapsed or refractory osteosarcoma GSK’s B7-H3-targeted antibody-drug conjugate, GSK5764227 (GSK’227), received Breakthrough Therapy Designation […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest 04 Jan to 10 Jan 2025
Araris Biotech announces research collaboration and option to license agreement with Chugai Pharmaceutical to develop next-generation ADCs using Araris’ AraLinQ technology

Weekly Digest – January 2025 Weekly Digest – January 2025 08 Jan 2025: Araris Biotech announces research collaboration and option to license agreement with Chugai Pharmaceutical to develop next-generation ADCs using Araris’ AraLinQ technology Chugai Pharmaceutical and Araris Biotech have […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest 04 Jan to 10 Jan 2025
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development

Weekly Digest – January 2025 Weekly Digest – January 2025 09 Jan 2025: Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development Samsung Biologics has extended its collaboration with LigaChem Biosciences to provide ADC services targeting the growing global […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest 04 Jan to 10 Jan 2025
PostEra announces expansion to $610M in their AI drug discovery collaboration with Pfizer

Weekly Digest – January 2025 Weekly Digest – January 2025 07 Jan 2025: PostEra announces expansion to $610M in their AI drug discovery collaboration with Pfizer PostEra has expanded its partnership with Pfizer to include a new ADC collaboration and […]

by Sandhya Ramalingam

Continue Reading
« First‹ Previous555657585960616263Next ›Last »
Page 59 of 63


Contact:

  info@ciscientists.com

 +1-908-212-7484

Optimal Dose

For a subscription, please provide your email id